Short Interest in First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) Decreases By 56.2%

First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) saw a significant decrease in short interest during the month of January. As of January 30th, there was short interest totaling 24,107 shares, a decrease of 56.2% from the January 15th total of 55,046 shares. Approximately 2.3% of the shares of the company are short sold. Based on an average daily volume of 817,638 shares, the days-to-cover ratio is presently 0.0 days. Based on an average daily volume of 817,638 shares, the days-to-cover ratio is presently 0.0 days. Approximately 2.3% of the shares of the company are short sold.

Institutional Investors Weigh In On First Trust NYSE Arca Biotechnology Index Fund

Hedge funds have recently added to or reduced their stakes in the stock. High Point Wealth Management LLC acquired a new position in shares of First Trust NYSE Arca Biotechnology Index Fund during the fourth quarter valued at $26,000. Russell Investments Group Ltd. lifted its position in First Trust NYSE Arca Biotechnology Index Fund by 7,900.0% in the 3rd quarter. Russell Investments Group Ltd. now owns 160 shares of the company’s stock valued at $29,000 after purchasing an additional 158 shares during the last quarter. Rossby Financial LCC boosted its stake in First Trust NYSE Arca Biotechnology Index Fund by 160.0% during the 3rd quarter. Rossby Financial LCC now owns 169 shares of the company’s stock valued at $31,000 after purchasing an additional 104 shares during the period. Capital Investment Advisory Services LLC grew its position in First Trust NYSE Arca Biotechnology Index Fund by 63.1% in the 3rd quarter. Capital Investment Advisory Services LLC now owns 181 shares of the company’s stock worth $32,000 after purchasing an additional 70 shares during the last quarter. Finally, Hazlett Burt & Watson Inc. grew its position in First Trust NYSE Arca Biotechnology Index Fund by 101.0% in the 3rd quarter. Hazlett Burt & Watson Inc. now owns 201 shares of the company’s stock worth $36,000 after purchasing an additional 101 shares during the last quarter.

First Trust NYSE Arca Biotechnology Index Fund Stock Performance

Shares of First Trust NYSE Arca Biotechnology Index Fund stock traded down $4.97 on Thursday, reaching $204.96. 89,881 shares of the company were exchanged, compared to its average volume of 313,527. The firm has a market cap of $215.21 million, a price-to-earnings ratio of 21.72 and a beta of 0.65. First Trust NYSE Arca Biotechnology Index Fund has a 1-year low of $141.38 and a 1-year high of $224.94. The company’s 50-day moving average is $212.49 and its two-hundred day moving average is $194.09.

First Trust NYSE Arca Biotechnology Index Fund Company Profile

The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is managed by First Trust.